Detalhe da pesquisa
1.
Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review.
Ann Surg Oncol
; 31(2): 1148-1170, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996640
2.
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.
Nature
; 551(7681): 512-516, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132146
3.
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.
Proc Natl Acad Sci U S A
; 117(46): 28960-28970, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127761
4.
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Oncologist
; 27(3): e286-e293, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274718
5.
A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study.
Invest New Drugs
; 38(4): 1137-1144, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707687
6.
Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review.
Ann Surg Oncol
; 31(3): 1495-1496, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133860
8.
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 122(3): 411-9, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26540173
10.
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.
Lancet Oncol
; 16(3): 293-300, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681967
11.
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
Clin Genitourin Cancer
; : 102052, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461085
12.
Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 16(5)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473213
13.
Lymph node yield: Impact on oncologic outcomes in oral cavity cancer.
Head Neck
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344842
14.
Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre's Real-World Experience.
Curr Oncol
; 30(10): 8928-8935, 2023 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37887545
15.
Sarcopenia in Men With Bone-Predominant Metastatic Castration-Resistant Prostate Cancer Undergoing Ra-223 Therapy.
Clin Genitourin Cancer
; 21(4): e228-e235.e1, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849325
16.
A cost-utility analysis of apalutamide for metastatic castrationsensitive prostate cancer.
Can Urol Assoc J
; 16(3): E126-E131, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672942
17.
Prostate Cancer Brain Metastasis: Review of a Rare Complication with Limited Treatment Options and Poor Prognosis.
J Clin Med
; 11(14)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887929
18.
Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
Oral Oncol
; 130: 105903, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569318
19.
Population-Based Study of Docetaxel or Abiraterone Effectiveness and Predictive Markers of Progression Free Survival in Metastatic Castration-Sensitive Prostate Cancer.
Front Oncol
; 11: 658331, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026638
20.
Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis.
Eur Urol Open Sci
; 21: 61-68, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34337469